Affecting more than 71 million people, Hepatitis C (HCV) is a growing international health concern. Left untreated, HCV can cause serious health problems including liver damage, liver cancer, and even death.
It doesn't have to be this way.
Treatment can cure more than 95% of people with Hepatitis C, but access to diagnosis is far too low. Ending an epidemic starts with testing.
Introducing bioLytical's INSTI® HCV Antibody Test - now CE Marked, with FDA Approval to follow.
The INSTI® HCV Antibody Test is the world’s first one minute test. It is highly accurate, affordable, and easy-to-use. The platform is an entirely portable system requiring no additional equipment, allowing providers to perform the test in multiple settings, from clinical labs to remote testing centers. With IgG and IgM procedural control and the ability to test for HCV genotypes 1 – 6, the INSTI HCV Antibody Test is an excellent tool in the fight against Hepatitis C.
Contact us to find out more.